Airwheel Announces Expanded Global Deployment of AI-Enabled Rideable Smart Electric Cabin Suitcase 
Casa Minerals Inc Announces Closing of Oversubscribed Private Placement, and Retains European Marketing Firm for Investor Awareness Services 
GTJAI Sponsored Axera’s Listing on the Main Board of HKEX 
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran 
Focus Graphite Engages Dr. Reuter Investor Relations to Expand German and European Capital Markets Presence Hemogenyx Pharmaceuticals PLC Announces Conversion of Convertible Loan Notes
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS…
This Week on MoneyTV with Donald Baillargeon, 3/26
HOLLYWOOD, CA / ACCESSWIRE / March 26, 2021 / Self-driving cars, solar power, Covid testing,…
T Stamp Inc – Identity & Trust Verification Tool Patent Granted
Trust Stamp Granted Patent for Identity and Trust Verification Tool ATLANTA, GA / ACCESSWIRE /…
Imerge Pro 2021: The bokeh king of image post-production
The most exciting image post-production tool on the market is back, and this time, it’s…
Novadiscovery announces new clinical simulation collaboration with Takeda
Novadiscovery announces new clinical simulation collaboration with Takeda Lyon, France – 26 March, 2021 Novadiscovery…
UCB SA/NV – Convening notice annual shareholders meeting
*** Unofficial English translation – For convenience purposes only *** UCB SA/NV – Public Limited…
Design Therapeutics Announces Pricing of Initial Public Offering
CARLSBAD, Calif., March 25, 2021 (GLOBE NEWSWIRE) — Design Therapeutics, Inc., a biotechnology company developing…
Gain Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option to Purchase Additional Shares
BETHESDA, Md., March 25, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain”) today announced the…
Vor Reports Fiscal Year 2020 Financial Results
IND accepted for VOR33, Vor’s lead eHSC product candidate for treatment of AML Completed initial…
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
Announced updated STS101 development plan featuring a new Phase 3 efficacy trial scheduled to begin…
Universe Pharmaceuticals INC Announces Closing of Initial Public Offering
Ji’an, Jiangxi, China, March 25, 2021 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
EyeGate Pharma Reports Full Year 2020 Financial Results and Provides Business Update
WALTHAM, Mass., March 25, 2021 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or…
CymaBay Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update
Actively recruiting patients in two global, clinical studies evaluating seladelpar in primary biliary cholangitis (PBC):…
Notice of Settlement of Derivative Suits
NEWTON, Mass., March 25, 2021 (GLOBE NEWSWIRE) — IN THE UNITED STATES DISTRICT COURT FOR…
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
MINNEAPOLIS, March 25, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
Progressed lead programs VRDN-001 and VRDN-002 towards clinical trials in Thyroid Eye Disease (TED); both…
ADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial Results
Achieved Full Year 2020 Total Revenues of $42.2 Million, a 44% Increase Over Full Year…
Eyenovia Reports Fourth Quarter and Full Year 2020 Financial Results
Announces MydCombi expected PDUFA date of October 28, 2021 Completes patient enrollment in Phase 3…
Trevi Therapeutics Announces Fourth Quarter and Year End 2020 Financial Results and Business Updates
Expects to Complete Enrollment and Report Top-Line Data of the Phase 2b/3 PRISM Trial in…
Histogen Appoints Rochelle Fuhrmann to Board of Directors
SAN DIEGO, March 25, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics…